Michael Lee Milligan
CFO & Principal Accounting OfficerMr. Michael Lee Milligan is CFO Neumora Therapeutics, Inc. from February 14, 2025. Mr. Milligan was Principal Accounting Officer of Neumora Therapeutics, Inc. Mr. Milligan served as the Vice President Finance for Y-mAbs Therapeutics, Inc., a biopharmaceutical company, from August 2018 to December 2021 and as the Vice President Finance & Controller at Acorda Therapeutics, Inc., a biotechnology company, from December 2016 to July 2018. Mr. Milligan also previously served as the Chief Financial Officer of New Haven Pharmaceuticals, Inc., a pharmaceutical company, from November 2014 to November 2016 and the Vice President and Chief Accounting Officer of Shinonogi Inc., a pharmaceutical company, from October 2008 to November 2014. Mr. Milligan holds a B.B.A. in Accounting from the University of Miami and an M.B.A. from Georgia State University.
Positions
- Company NameNeumora Therapeutics, Inc.Stock CodeNMRAPositionCFO & Principal Accounting Officer
